Novacyt S.A. (CDI) (NCYT) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Novacyt S.A. (CDI)

NOTE: This is based on 23 open tips for Novacyt S.A. (CDI) (NCYT)


Novacyt S.A. (CDI) (NCYT)
Latest Quote Price

68.10p

Novacyt S.A. (CDI) (NCYT)
Price Change (%)

-1.96%


Latest Bid : 66.20p Latest Ask : 70.60p
High Today : 74.00p Low Today : 67.21p
This Years High : 80.30p This Years Low : 36.90p
Volume : 78,301 MKT Cap : £49.42M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only


Novacyt S.A. (CDI) (NCYT) Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

Novacyt S.A. (CDI) (NCYT) Latest Tips

Type Tipster SectorScore Start date Performance
Sell Tom Winnifrith Premium Only 2024-02-06 10:30:00 06/02/2024 -50.21%
Sell Steve Moore Premium Only 2023-01-26 13:50:00 26/01/2023 5.29%
Sell Tom Winnifrith Premium Only 2022-04-26 14:35:00 26/04/2022 57.47%
Sell Tom Winnifrith Premium Only 2022-01-30 08:25:00 30/01/2022 59.66%
Sell Tom Winnifrith Premium Only 2022-01-10 13:40:00 10/01/2022 77.66%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Novacyt S.A. (CDI) (NCYT) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 66.20p Latest Ask : 70.60p
High Today : 74.00p Low Today : 67.21p
This Years High : 80.30p This Years Low : 36.90p
Volume : 78,301 MKT Cap : £49.42M

Novacyt S.A. (CDI) Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Novacyt S.A. (CDI) Tips

Type Tipster SectorScore Start date Performance
Sell Tom Winnifrith Premium Only 2024-02-06 10:30:00 06/02/2024 -50.21%
Sell Steve Moore Premium Only 2023-01-26 13:50:00 26/01/2023 5.29%
Sell Tom Winnifrith Premium Only 2022-04-26 14:35:00 26/04/2022 57.47%
Sell Tom Winnifrith Premium Only 2022-01-30 08:25:00 30/01/2022 59.66%
Sell Tom Winnifrith Premium Only 2022-01-10 13:40:00 10/01/2022 77.66%